Cortina Asset Management’s NovoCure NVCR Stock Holding History

Cortina Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$8.94M	Buy	141,352 +16,291	+13%	+$825K	0.55%	67
2019 Q1	$6.02M	Sell	125,061 -3,858	-3%	-$186K	0.38%	113
2018 Q4	$4.32M	Sell	128,919 -7,156	-5%	-$262K	0.26%	147
2018 Q3	$7.13M	Sell	136,075 -170,606	-56%	-$6.79M	0.33%	107
2018 Q2	$9.6M	Sell	306,681 -99,788	-25%	-$2.78M	0.45%	67
2018 Q1	$8.86M	Sell	406,469 -54,779	-12%	-$1.18M	0.44%	74
2017 Q4	$9.32M	Buy	461,248 +203,728	+79%	+$3.92M	0.41%	73
2017 Q3	$5.11M	Buy	+257,520	New	+$5.06M	0.21%	176

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCP

Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Cortina Asset Management's NVCR Position: Q2 2019 in Review

Cortina Asset Management increased its NovoCure (NVCR) stake by 13% in Q2 2019, buying an estimated $825K and bringing the position to 141,352 shares worth $8.94M. The position accounts for 0.55% of the portfolio, ranked #67.

Cortina Asset Management first reported a position in NVCR in Q3 2017 and has held it in 8 quarters since. The position peaked at $9.6M in Q2 2018. 197 funds tracked by Wall St. Rank hold NVCR as of Q2 2019.

Cortina Asset Management held 141,352 shares of NovoCure worth $8.94M as of Q2 2019.
Cortina Asset Management bought 16,291 NovoCure shares in Q2 2019, an estimated $825K.
NovoCure made up 0.55% of Cortina Asset Management's portfolio in Q2 2019, its #67 holding.
Cortina Asset Management first reported a position in NovoCure in Q3 2017 and has held it in 8 quarters since.
Cortina Asset Management's NovoCure position peaked at $9.6M in Q2 2018.
197 funds tracked by Wall St. Rank held NovoCure as of Q2 2019.

Based on Cortina Asset Management's 13F filing for Q2 2019, filed 2 Jul 2019.